Cytomos is a series a startup based in United Kingdom. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
Cytomos develops novel cell analysis and sorting tools for bioprocessing and cell therapy applications. Their technology enables rapid, label-free, single-cell analysis, providing detailed insights into cell health and behavior.
Stage
series-a
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky